TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced the Canadian launch of 1,000mg dosage strength of Glumetza™, a once-daily, extended-release formulation of metformin hydrochloride (HCl) for the treatment of type 2 diabetes.
